Toll Free: +1-855-465-4651 |  sales@marketnreports.com

Find Top Market Research Reports here

Home  >>   Pharmaceuticals & Healthcare  >>   Reports   >>  

Global Melanoma Drugs Market 2017 Industry, Analysis, Share, Growth, Sales, Trends, Supply, Forecast to 2022

 Published Date : Oct-2017   |    Format :PDF   |    Number of Pages : 103
This report studies the global Melanoma Drugs market, analyzes and researches the Melanoma Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Bristol-Myers Squibb
    Enzon Pharmaceuticals
    Exelixis
    GlaxoSmithKline
    Merck
    Pfizer
    Janssen Biotech
    Hoffmann-La Roche Ltd
    Navidea Biopharmaceuticals
    Novartis
    Ono Pharmaceutical
    Amgen

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, Melanoma Drugs can be split into
    Immunotherapy
    Targeted Therapy
    Other

Market segment by Application, Melanoma Drugs can be split into
    Hospitals
    Clinics
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Melanoma Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Melanoma Drugs
    1.1  Melanoma Drugs Market Overview
        1.1.1 Melanoma Drugs Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Melanoma Drugs Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Melanoma Drugs Market by Type
        1.3.1 Immunotherapy
        1.3.2 Targeted Therapy
        1.3.3 Other
    1.4 Melanoma Drugs Market by End Users/Application
        1.4.1 Hospitals
        1.4.2 Clinics
        1.4.3 Other

2 Global Melanoma Drugs Competition Analysis by Players
    2.1 Melanoma Drugs Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Bristol-Myers Squibb
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Melanoma Drugs Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Enzon Pharmaceuticals
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Melanoma Drugs Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Exelixis
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Melanoma Drugs Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 GlaxoSmithKline
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Melanoma Drugs Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Merck
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Melanoma Drugs Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Pfizer
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Melanoma Drugs Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Janssen Biotech
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Melanoma Drugs Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Hoffmann-La Roche Ltd
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Melanoma Drugs Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Navidea Biopharmaceuticals
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Melanoma Drugs Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Novartis
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Melanoma Drugs Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Ono Pharmaceutical
    3.12 Amgen

4 Global Melanoma Drugs Market Size by Type and Application (2012-2017)
    4.1 Global Melanoma Drugs Market Size by Type (2012-2017)
    4.2 Global Melanoma Drugs Market Size by Application (2012-2017)
    4.3 Potential Application of Melanoma Drugs in Future
    4.4 Top Consumer/End Users of Melanoma Drugs

5 United States Melanoma Drugs Development Status and Outlook
    5.1 United States Melanoma Drugs Market Size (2012-2017)
    5.2 United States Melanoma Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Melanoma Drugs Development Status and Outlook
    6.1 EU Melanoma Drugs Market Size (2012-2017)
    6.2 EU Melanoma Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Melanoma Drugs Development Status and Outlook
    7.1 Japan Melanoma Drugs Market Size (2012-2017)
    7.2 Japan Melanoma Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Melanoma Drugs Development Status and Outlook
    8.1 China Melanoma Drugs Market Size (2012-2017)
    8.2 China Melanoma Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Melanoma Drugs Development Status and Outlook
    9.1 India Melanoma Drugs Market Size (2012-2017)
    9.2 India Melanoma Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Melanoma Drugs Development Status and Outlook
    10.1 Southeast Asia Melanoma Drugs Market Size (2012-2017)
    10.2 Southeast Asia Melanoma Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Melanoma Drugs Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Melanoma Drugs Revenue and Growth Rate (2017-2022)
        11.1.2 EU Melanoma Drugs Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Melanoma Drugs Revenue and Growth Rate (2017-2022)
        11.1.4 China Melanoma Drugs Revenue and Growth Rate (2017-2022)
        11.1.5 India Melanoma Drugs Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Melanoma Drugs Revenue and Growth Rate (2017-2022)
    11.2 Global Melanoma Drugs Market Size (Value) by Type (2017-2022)
    11.3 Global Melanoma Drugs Market Size by Application (2017-2022)

12 Melanoma Drugs Market Dynamics
    12.1 Melanoma Drugs Market Opportunities
    12.2 Melanoma Drugs Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Melanoma Drugs Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Melanoma Drugs Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures

    Figure Melanoma Drugs Product Scope
    Figure Global Melanoma Drugs Market Size (Million USD) (2012-2017)
    Table Global Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Melanoma Drugs Market Share by Regions in 2016
    Figure United States Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure EU Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Japan Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure China Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure India Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Southeast Asia Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Melanoma Drugs Market Share by Type in 2016
    Figure Immunotherapy Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Targeted Therapy Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Global Melanoma Drugs Market Share by Application in 2016
    Table Key Downstream Customer in Hospitals
    Figure Melanoma Drugs Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
    Table Key Downstream Customer in Clinics
    Figure Melanoma Drugs Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
    Table Key Downstream Customer in Other
    Figure Melanoma Drugs Market Size (Million USD) and Growth Rate in Other (2012-2017)
    Table Melanoma Drugs Market Size (Million USD) by Players (2016 and 2017)
    Figure Melanoma Drugs Market Size Share by Players in 2016
    Figure Melanoma Drugs Market Size Share by Players in 2017
    Table Bristol-Myers Squibb Basic Information List
    Table Melanoma Drugs Business Revenue (Million USD) of Bristol-Myers Squibb (2012-2017)
    Figure Bristol-Myers Squibb Melanoma Drugs Business Revenue Market Share in 2016
    Table Enzon Pharmaceuticals Basic Information List
    Table Melanoma Drugs Business Revenue (Million USD) of Enzon Pharmaceuticals (2012-2017)
    Figure Enzon Pharmaceuticals Melanoma Drugs Business Revenue Market Share in 2016
    Table Exelixis Basic Information List
    Table Melanoma Drugs Business Revenue (Million USD) of Exelixis (2012-2017)
    Figure Exelixis Melanoma Drugs Business Revenue Market Share in 2016
    Table GlaxoSmithKline Basic Information List
    Table Melanoma Drugs Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
    Figure GlaxoSmithKline Melanoma Drugs Business Revenue Market Share in 2016
    Table Merck Basic Information List
    Table Melanoma Drugs Business Revenue (Million USD) of Merck (2012-2017)
    Figure Merck Melanoma Drugs Business Revenue Market Share in 2016
    Table Pfizer Basic Information List
    Table Melanoma Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
    Figure Pfizer Melanoma Drugs Business Revenue Market Share in 2016
    Table Janssen Biotech Basic Information List
    Table Melanoma Drugs Business Revenue (Million USD) of Janssen Biotech (2012-2017)
    Figure Janssen Biotech Melanoma Drugs Business Revenue Market Share in 2016
    Table Hoffmann-La Roche Ltd Basic Information List
    Table Melanoma Drugs Business Revenue (Million USD) of Hoffmann-La Roche Ltd (2012-2017)
    Figure Hoffmann-La Roche Ltd Melanoma Drugs Business Revenue Market Share in 2016
    Table Navidea Biopharmaceuticals Basic Information List
    Table Melanoma Drugs Business Revenue (Million USD) of Navidea Biopharmaceuticals (2012-2017)
    Figure Navidea Biopharmaceuticals Melanoma Drugs Business Revenue Market Share in 2016
    Table Novartis Basic Information List
    Table Melanoma Drugs Business Revenue (Million USD) of Novartis (2012-2017)
    Figure Novartis Melanoma Drugs Business Revenue Market Share in 2016
    Table Ono Pharmaceutical Basic Information List
    Table Melanoma Drugs Business Revenue (Million USD) of Ono Pharmaceutical (2012-2017)
    Figure Ono Pharmaceutical Melanoma Drugs Business Revenue Market Share in 2016
    Table Amgen Basic Information List
    Table Melanoma Drugs Business Revenue (Million USD) of Amgen (2012-2017)
    Figure Amgen Melanoma Drugs Business Revenue Market Share in 2016
    Table Global Melanoma Drugs Market Size (Million USD) by Type (2012-2017)
    Figure Global Melanoma Drugs Market Size Share by Type in 2012
    Figure Global Melanoma Drugs Market Size Share by Type in 2013
    Figure Global Melanoma Drugs Market Size Share by Type in 2014
    Figure Global Melanoma Drugs Market Size Share by Type in 2015
    Figure Global Melanoma Drugs Market Size Share by Type in 2016
    Figure Global Melanoma Drugs Market Size Share by Type in 2017
    Table Global Melanoma Drugs Market Size (Million USD) by Application (2012-2017)
    Figure Global Melanoma Drugs Market Size (Million USD) by Application in 2012
    Figure Global Melanoma Drugs Market Size (Million USD) by Application in 2013
    Figure Global Melanoma Drugs Market Size (Million USD) by Application in 2014
    Figure Global Melanoma Drugs Market Size (Million USD) by Application in 2015
    Figure Global Melanoma Drugs Market Size (Million USD) by Application in 2016
    Figure Global Melanoma Drugs Market Size (Million USD) by Application in 2017
    Table Top Consumer/End Users of Melanoma Drugs
    Figure United States Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table United States Melanoma Drugs Market Size (Million USD) by Players (2012-2017)
    Figure United States Melanoma Drugs Market Size Share by Players in 2016
    Figure United States Melanoma Drugs Market Size Share by Players in 2017
    Figure EU Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table EU Melanoma Drugs Market Size (Million USD) by Players (2012-2017)
    Figure EU Melanoma Drugs Market Size Share by Players in 2016
    Figure EU Melanoma Drugs Market Size Share by Players in 2017
    Figure Japan Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Japan Melanoma Drugs Market Size (Million USD) by Players (2012-2017)
    Figure Japan Melanoma Drugs Market Size Share by Players in 2016
    Figure Japan Melanoma Drugs Market Size Share by Players in 2017
    Figure China Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table China Melanoma Drugs Market Size (Million USD) by Players (2012-2017)
    Figure China Melanoma Drugs Market Size Share by Players in 2016
    Figure China Melanoma Drugs Market Size Share by Players in 2017
    Figure India Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table India Melanoma Drugs Market Size (Million USD) by Players (2012-2017)
    Figure India Melanoma Drugs Market Size Share by Players in 2016
    Figure India Melanoma Drugs Market Size Share by Players in 2017
    Figure Southeast Asia Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Southeast Asia Melanoma Drugs Market Size (Million USD) by Players (2012-2017)
    Figure Southeast Asia Melanoma Drugs Market Size Share by Players in 2016
    Figure Southeast Asia Melanoma Drugs Market Size Share by Players in 2017
    Figure Global Melanoma Drugs Market Size (Million USD) by Regions (2017-2022)
    Table Global Melanoma Drugs Market Size (Million USD) by Regions (2017-2022)
    Figure Global Melanoma Drugs Market Size Share by Regions in 2017
    Figure Global Melanoma Drugs Market Size Share by Regions in 2022
    Figure United States Melanoma Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure EU Melanoma Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Japan Melanoma Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure China Melanoma Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure India Melanoma Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Southeast Asia Melanoma Drugs Revenue (Million USD) and Growth Rate (2017-2022)
    Table Global Melanoma Drugs Market Size (Million USD) by Type (2017-2022)
    Figure Global Melanoma Drugs Market Size Share by Type in 2017
    Figure Global Melanoma Drugs Market Size Share by Type in 2022
    Table Global Melanoma Drugs Market Size (Million USD) by Application (2017-2022)
    Figure Global Melanoma Drugs Market Size (Million USD) by Application in 2017
    Figure Global Melanoma Drugs Market Size (Million USD) by Application in 2022



Latest News
Read more